Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis

OBJECTIVE: To evaluate the long-term safety and efficacy of sarilumab with/without conventional synthetic (cs)DMARDs in RA. METHODS: The analyses evaluated two open-label extensions (OLEs): EXTEND and MONARCH OLE, which included patients from six randomized trials. Patients received sarilumab 200 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Burmester, Gerd R, Strand, Vibeke, Kivitz, Alan J, Hu, Chih-Chi, Wang, Sheldon, van Hoogstraten, Hubert, Klier, Gabriella L, Fleischmann, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547516/
https://www.ncbi.nlm.nih.gov/pubmed/36727470
http://dx.doi.org/10.1093/rheumatology/kead062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547516/
https://www.ncbi.nlm.nih.gov/pubmed/36727470
http://dx.doi.org/10.1093/rheumatology/kead062

Ejemplares similares